Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model
- 24 February 2009
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 66 (2) , 162-168
- https://doi.org/10.1016/j.lungcan.2009.01.016
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cellsMolecular Cancer Therapeutics, 2006
- Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applicationsLife Sciences, 2006
- Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer*Chest, 2003
- Activity-Guided Fractionation of Green Tea Extract with Antiproliferative Activity against Human Stomach Cancer Cells.Biological & Pharmaceutical Bulletin, 2002
- Subchronic toxicity study of gallic acid by oral administration in F344 ratsFood and Chemical Toxicology, 2001
- Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in miceAnti-Cancer Drugs, 2001
- INHIBITION OF CARCINOGENESIS BY DIETARY POLYPHENOLIC COMPOUNDSAnnual Review of Nutrition, 2001
- Importance of a pyrogallol-type structure in catechin compounds for apoptosis-inducing activityPhytochemistry, 2000
- Tea catechins and related polyphenols as anti‐cancer agentsBioFactors, 2000
- Induction of apoptosis by gallic acid in lung cancer cellsAnti-Cancer Drugs, 1999